Back

Molecular pathology of acute respiratory distress syndrome, mechanical ventilation and abnormal coagulation in severe COVID-19

Soule, A.; Ma, W. R.; Liu, K. Y.; Allard, C.; Qureshi, S.; Tremblay, K.; Emad, A.; Rousseau, S.

2023-03-10 respiratory medicine
10.1101/2023.03.09.23286797
Show abstract

Systemic inflammation in critically ill patients can lead to serious consequences such as acute respiratory distress syndrome (ARDS), a condition characterized by the presence of lung inflammation, edema, and impaired gas exchange, associated with poor survival. Understanding molecular pathobiology is essential to improve critical care of these patients. To this end, we use multimodal profiles of SARS-CoV-2 infected hospitalized participants to the Biobanque Quebecoise de la COVID-19 (BQC-19) to characterize endophenotypes associated with different degrees of disease severity. Proteomic, metabolomic, and genomic characterization supported a role for neutrophil-associated procoagulant activity in severe COVID-19 ARDS that is inversely correlated with sphinghosine-1 phosphate plasma levels. Fibroblast Growth Factor Receptor (FGFR) and SH2-containing transforming protein 4 (SHC4) signaling were identified as molecular features associated with endophenotype 6 (EP6). Mechanical ventilation in EP6 was associated with alterations in lipoprotein metabolism. These findings help define the molecular mechanisms related to specific severe outcomes, that can be used to identify early unfavorable clinical trajectories and treatable traits to improve the survival of critically ill patients.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
iScience
based on 74 papers
Top 0.1%
11.0%
2
Respiratory Research
based on 10 papers
Top 0.1%
10.1%
3
Scientific Reports
based on 701 papers
Top 29%
6.3%
4
European Respiratory Journal
based on 44 papers
Top 1%
5.3%
5
Nature Communications
based on 483 papers
Top 15%
5.3%
6
PLOS ONE
based on 1737 papers
Top 68%
5.0%
7
Frontiers in Immunology
based on 140 papers
Top 2%
4.5%
8
Signal Transduction and Targeted Therapy
based on 10 papers
Top 0.1%
4.5%
50% of probability mass above
9
Clinical and Translational Medicine
based on 11 papers
Top 0.1%
4.5%
10
EMBO Molecular Medicine
based on 15 papers
Top 0.2%
2.8%
11
The American Journal of Pathology
based on 11 papers
Top 0.5%
2.8%
12
JCI Insight
based on 63 papers
Top 2%
2.8%
13
Critical Care
based on 14 papers
Top 0.6%
2.8%
14
American Journal of Respiratory and Critical Care Medicine
based on 23 papers
Top 0.7%
2.5%
15
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 0.6%
2.4%
16
Cell
based on 28 papers
Top 1%
1.6%
17
Clinical Immunology
based on 12 papers
Top 0.7%
1.6%
18
PLOS Pathogens
based on 35 papers
Top 1.0%
1.6%
19
eLife
based on 262 papers
Top 25%
1.2%
20
Proceedings of the National Academy of Sciences
based on 100 papers
Top 13%
0.8%
21
ERJ Open Research
based on 36 papers
Top 3%
0.8%
22
Cells
based on 14 papers
Top 2%
0.7%
23
Critical Care Explorations
based on 15 papers
Top 2%
0.7%
24
Allergy
based on 13 papers
Top 2%
0.7%
25
BMJ Open Respiratory Research
based on 32 papers
Top 3%
0.7%